![Hero Image](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fbanner-two-shape-left.6c4ab631.png&w=3840&q=75)
![Hero Image](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fhero-right-top.b8bd1734.webp&w=3840&q=75)
Last updated at 23 hours ago
Director
DIN: 02793333
Rustom Farhad Ginwalla is currently associated with 2 companies as Director. They serve as a Director at D R S MEDICAL CENTRE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02793333.Rustom Farhad Ginwalla is currently involved in 1 different role. Their most recent position is with APEIRO BIO SCIENCES PRIVATE LIMITED as a Director. The first company Rustom Farhad Ginwalla was appointed to as a director was D R S MEDICAL CENTRE PRIVATE LIMITED. Rustom Farhad Ginwalla is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Rustom Farhad Ginwalla is currently associated with 2 companies as Director. They serve as a Director at D R S MEDICAL CENTRE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02793333.Rustom Farhad Ginwalla is currently involved in 1 different role. Their most recent position is with APEIRO BIO SCIENCES PRIVATE LIMITED as a Director. The first company Rustom Farhad Ginwalla was appointed to as a director was D R S MEDICAL CENTRE PRIVATE LIMITED. Rustom Farhad Ginwalla is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
6 Years 3 Years Interval
Company Name | Designation | Date of Appointment |
---|---|---|
D R S MEDICAL CENTRE PRIVATE LIMITED | Director | 25-Feb-1995 |
APEIRO BIO SCIENCES PRIVATE LIMITED | Director | 11-Apr-2024 |